V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10450297 | 10034156 | 1.76 | 85.8 | Palliative (P) | 2020-05-07 | 2020-05-28 | Capecitabine | 02 | N | CAPECITABINE | 100874774 |
| 10450304 | 10034157 | 1.73 | 70 | Palliative (P) | 2019-07-15 | 2019-07-17 | CHOP R | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101346665 |
| 10450330 | 10034158 | 1.78 | 62 | Palliative (P) | 2019-12-18 | 2019-12-25 | Capecitabine | N | N | CAPECITABINE | 101069957 |
| 10450347 | 10034159 | 1.67 | 105.75 | Curative (C) | 2016-11-20 | 2016-12-03 | Rituximab | 02 | N | RITUXIMAB | 100711466 |
| 10450365 | 10034160 | 1.67 | 107.2 | Neo-adjuvant (N) | 2017-01-10 | 2017-01-20 | CAPECITABINE + OXALIPLATIN | 02 | Y | CAPECITABINE + OXALIPLATIN | 100169034 |
| 10450374 | 10034161 | 1.84 | 83 | Adjuvant (A) | 2018-06-27 | 2018-07-07 | Rituximab (Maintenance) | 02 | N | RITUXIMAB | 100222298 |
| 10450381 | 10034162 | 1.82 | 71.5 | Palliative (P) | 2019-02-20 | 2019-02-20 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100150275 |
| 10450385 | 10034163 | 1.75 | 73 | Curative (C) | 2019-10-17 | 2019-11-15 | CAPECITABINE + OXALIPLATIN | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100326533 |
| 10450407 | 10034164 | 1.63 | 54.7 | null | 2016-05-19 | 2016-06-16 | Rituximab | 02 | N | RITUXIMAB | 100240481 |
| 10450409 | 10034165 | 1.66 | null | Palliative (P) | 2017-08-05 | 2017-08-18 | CAPECITABINE + OXALIPLATIN | 02 | N | RITUXIMAB | 101297247 |
| 10450421 | 10034166 | 1.7 | 83 | Adjuvant (A) | 2016-04-03 | 2016-04-04 | Rituximab (Maintenance) | 02 | N | RITUXIMAB | 100887522 |
| 10450428 | 10034167 | 1.74 | 70.5 | null | 2021-06-07 | 2021-06-08 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE | 100675193 |
| 10450445 | 10034168 | 1.75 | 0 | Palliative (P) | 2017-07-25 | 2017-08-09 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE | 100580218 |
| 10450452 | 10034169 | 1.75 | 121 | Curative (C) | 2017-05-19 | 2017-05-22 | Capecitabine + Oxaliplatin 21day | N | N | CAPECITABINE + OXALIPLATIN | 101057329 |
| 10450460 | 10034170 | null | null | null | 2021-05-24 | 2022-03-30 | Capecitabine + Oxaliplatin 21day | 02 | null | DOCETAXEL | 100292107 |
| 10450461 | 10034171 | 1.76 | 60.4 | Curative (C) | 2016-09-07 | 2016-09-07 | CAPECITABINE + OXALIPLATIN | 02 | Y | CAPECITABINE + OXALIPLATIN | 100871653 |
| 10450470 | 10034172 | 1.84 | 78 | Palliative (P) | 2018-10-14 | 2018-10-14 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100508408 |
| 10450478 | 10034173 | 1.6 | 91.7 | null | 2021-06-25 | 2021-07-05 | Capecitabine | 02 | null | CAPECITABINE | 101015111 |
| 10450483 | 10034174 | 1.56 | 81 | Adjuvant (A) | 2017-05-04 | 2017-05-04 | Capecitabine + Oxaliplatin 21day | 02 | N | PEMBROLIZUMAB | 100674181 |
| 10450487 | 10034175 | 1.86 | 102.8 | Curative (C) | 2019-05-29 | 2019-05-29 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100128254 |
| 10450539 | 10034176 | 1.65 | 53 | null | 2021-01-28 | 2021-11-14 | Rituximab | 02 | null | RITUXIMAB | 101241650 |
| 10450540 | 10034177 | null | 0 | null | 2017-12-30 | 2018-01-07 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE | 101508970 |
| 10450547 | 10034178 | 1.62 | 83.7 | null | 2022-01-22 | 2022-02-07 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100997566 |
| 10450556 | 10034179 | 1.72 | 70.4 | Adjuvant (A) | 2015-03-28 | 2015-03-29 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100781756 |
| 10450557 | 10034180 | 1.82 | 98.5 | Curative (C) | 2018-10-29 | 2018-10-30 | Capecitabine | 02 | N | CAPECITABINE | 101772545 |
| 10450561 | 10034181 | 1.6 | 62.5 | Palliative (P) | 2018-10-01 | 2018-10-22 | DOCETAXEL + Prednisolone | 02 | N | DOCETAXEL | 100757434 |
| 10450562 | 10034182 | 1.62 | 56 | null | 2022-01-18 | 2022-02-16 | Rituximab | 02 | null | RITUXIMAB | 100123599 |
| 10450582 | 10034183 | 1.5 | 82.4 | null | 2022-01-04 | 2022-01-06 | CHOP R | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101412951 |
| 10450606 | 10034184 | 1.68 | 100.8 | Neo-adjuvant (N) | 2017-09-10 | 2017-09-18 | CAPECITABINE + OXALIPLATIN | 02 | null | DOCETAXEL | 101546537 |
| 10450607 | 10034185 | 1.52 | 120 | Palliative (P) | 2016-06-14 | 2016-06-20 | IBRUTINIB | 02 | N | IBRUTINIB | 100507612 |
| 10450617 | 10034186 | 1.81 | 61.2 | Curative (C) | 2019-06-14 | 2019-06-19 | CAPECITABINE + OXALIPLATIN | 02 | N | DOCETAXEL | 100614985 |
| 10450618 | 10034187 | null | null | null | 2021-07-06 | 2021-07-18 | Docetaxel | 02 | null | DOCETAXEL | 101850787 |
| 10450627 | 10034188 | 1.65 | 80.55 | Palliative (P) | 2017-06-01 | 2017-06-14 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100434435 |
| 10450657 | 10034189 | 1.66 | 95 | null | 2022-04-15 | 2022-04-21 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 100540948 |
| 10450660 | 10034190 | 1.73 | 83.1 | Palliative (P) | null | 2019-03-07 | IBRUTINIB | 02 | N | IBRUTINIB | 101763599 |
| 10450663 | 10034191 | 1.69 | 96.2 | Palliative (P) | 2018-11-17 | 2018-11-25 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101680595 |
| 10450672 | 10034192 | 1.58 | 81.1 | null | null | 2020-12-25 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 100148805 |
| 10450681 | 10034193 | 1.57 | 71.4 | Palliative (P) | 2017-02-23 | 2017-03-08 | Rituximab | 02 | N | RITUXIMAB | 100470426 |
| 10450698 | 10034194 | 1.55 | 0 | Disease modification (D) | 2019-11-06 | 2019-11-16 | Capecitabine + Oxaliplatin 21day | N | N | CAPECITABINE + OXALIPLATIN | 101563196 |
| 10450720 | 10034195 | 1.6 | 67.8 | Palliative (P) | 2019-06-07 | 2019-06-07 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE | 101309366 |
| 10450725 | 10034196 | 1.5 | 82.4 | 03 | 2018-12-10 | 2018-12-10 | CAPECITABINE + OXALIPLATIN | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101732223 |
| 10450763 | 10034197 | 1.54 | 74.5 | Palliative (P) | 2019-01-11 | 2019-01-11 | Rituximab | null | null | RITUXIMAB | 100793727 |
| 10450777 | 10034199 | 1.69 | 78.4 | null | 2021-11-06 | 2021-12-11 | Docetaxel | 02 | null | DOCETAXEL | 101466734 |
| 10450782 | 10034200 | null | 66 | Curative (C) | 2017-03-31 | 2017-04-11 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101737155 |
| 10450802 | 10034201 | 1.57 | 61.75 | Curative (C) | 2016-04-21 | 2016-05-12 | CAPECITABINE + OXALIPLATIN | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101339221 |
| 10450817 | 10034202 | 1.69 | 69 | Curative (C) | 2019-10-04 | 2019-10-16 | CAPECITABINE + OXALIPLATIN | 02 | N | PEMBROLIZUMAB | 100416971 |
| 10450819 | 10034203 | 1.78 | 68 | Curative (C) | 2017-08-08 | 2017-08-14 | Docetaxel | 02 | N | DOCETAXEL | 100394246 |
| 10450845 | 10034204 | 1.62 | 89.1 | null | 2018-12-26 | 2019-01-10 | Capecitabine + Oxaliplatin 21day | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100931726 |
| 10450853 | 10034205 | 1.81 | 88.4 | Palliative (P) | 2019-02-09 | 2019-02-10 | Capecitabine | 02 | Y | CAPECITABINE | 101610618 |
| 10450854 | 10034206 | 1.65 | 54 | Palliative (P) | null | 2017-06-23 | Capecitabine + Oxaliplatin 21day | 02 | N | RITUXIMAB | 101428258 |